Prothena Corporation plc Ordinary Shares (PRTA) is a publicly traded Healthcare sector company. As of May 21, 2026, PRTA trades at $9.35 with a market cap of $502.07M and a P/E ratio of -3.28. PRTA moved +3.14% today. Year to date, PRTA is +2.75%; over the trailing twelve months it is +28.26%. Its 52-week range spans $4.32 to $20.75. Analyst consensus is buy with an average price target of $21.40. Rallies surfaces PRTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns PRTA stock?
Hedge funds tracked by Rallies that own PRTA include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Prothena Corporation plc Ordinary Shares.
PRTA Key Metrics
Key financial metrics for PRTA
Metric
Value
Price
$9.35
Market Cap
$502.07M
P/E Ratio
-3.28
EPS
$-2.81
Dividend Yield
0.00%
52-Week High
$20.75
52-Week Low
$4.32
Volume
0
Avg Volume
0
Revenue (TTM)
$57.94M
Net Income
$-151.18M
Gross Margin
0.00%
Top Hedge Funds Holding PRTA
Exoduspoint Capital holds 11.17K shares of PRTA, changed -87.30% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own PRTA include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Prothena Corporation plc Ordinary Shares.
Does Rallies show 13F holders for PRTA?
Yes. Rallies tracks hedge fund and 13F ownership data for PRTA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PRTA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRTA. It does not provide personalized investment advice.
